FDA approves Merck's Keytruda for use in lung cancer
October 02, 2015 at 14:01 PM EDT
Oct 2 (Reuters) - The U.S. Food and Drug Administration granted accelerated approval for Merck & Co's immunotherapy, Keytruda, in patients with a form of lung cancer.
